12:00 AM
 | 
Jun 18, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Angiopoietin-like 4 (ANGPTL4)

Ophthalmic disease

INDICATION: Diabetic retinopathy

In vitro studies suggest inhibiting ANGPTL4 could help treat proliferative diabetic retinopathy (PDR). ANGPTL4 levels were higher in aqueous fluid from the eyes of PDR patients than...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >